U.S. Physical Therapy, Inc. (NYSE:USPH) CEO Christopher J. Reading Sells 601 Shares

U.S. Physical Therapy, Inc. (NYSE:USPH) CEO Christopher J. Reading sold 601 shares of the stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $135.39, for a total transaction of $81,369.39. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Christopher J. Reading also recently made the following trade(s):

  • On Monday, August 19th, Christopher J. Reading sold 7,000 shares of U.S. Physical Therapy stock. The shares were sold at an average price of $135.13, for a total transaction of $945,910.00.
  • On Tuesday, May 21st, Christopher J. Reading sold 19,860 shares of U.S. Physical Therapy stock. The shares were sold at an average price of $119.36, for a total transaction of $2,370,489.60.

Shares of NYSE:USPH traded up $0.20 during trading on Monday, reaching $134.80. The company’s stock had a trading volume of 92,696 shares, compared to its average volume of 87,297. The company has a current ratio of 1.88, a quick ratio of 1.18 and a debt-to-equity ratio of 0.53. U.S. Physical Therapy, Inc. has a 12 month low of $98.69 and a 12 month high of $137.15. The firm’s 50 day simple moving average is $128.04 and its two-hundred day simple moving average is $116.23. The stock has a market capitalization of $1.71 billion, a PE ratio of 50.87, a price-to-earnings-growth ratio of 3.71 and a beta of 1.13.



U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.81 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.81. U.S. Physical Therapy had a net margin of 6.22% and a return on equity of 19.19%. The firm had revenue of $126.40 million during the quarter, compared to the consensus estimate of $124.86 million. During the same quarter last year, the firm earned $0.73 EPS. The firm’s revenue for the quarter was up 9.8% compared to the same quarter last year. Research analysts anticipate that U.S. Physical Therapy, Inc. will post 2.94 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 13th. Investors of record on Thursday, August 15th will be issued a $0.30 dividend. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.27. The ex-dividend date is Wednesday, August 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 0.89%. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 45.28%.

Several large investors have recently made changes to their positions in USPH. AE Wealth Management LLC increased its holdings in U.S. Physical Therapy by 61.4% during the second quarter. AE Wealth Management LLC now owns 4,369 shares of the company’s stock valued at $536,000 after buying an additional 1,662 shares during the period. Great West Life Assurance Co. Can increased its holdings in U.S. Physical Therapy by 7.6% during the first quarter. Great West Life Assurance Co. Can now owns 17,517 shares of the company’s stock valued at $1,838,000 after buying an additional 1,242 shares during the period. Copeland Capital Management LLC increased its holdings in U.S. Physical Therapy by 6.7% during the first quarter. Copeland Capital Management LLC now owns 174,084 shares of the company’s stock valued at $18,284,000 after buying an additional 10,902 shares during the period. Comerica Bank boosted its stake in U.S. Physical Therapy by 2.5% in the first quarter. Comerica Bank now owns 13,637 shares of the company’s stock valued at $1,512,000 after acquiring an additional 338 shares in the last quarter. Finally, Ontario Teachers Pension Plan Board acquired a new stake in U.S. Physical Therapy in the first quarter valued at approximately $703,000. 99.58% of the stock is owned by hedge funds and other institutional investors.

Several research analysts have commented on the stock. Zacks Investment Research raised shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $127.00 price objective for the company in a report on Friday, April 26th. Barrington Research reissued a “hold” rating on shares of U.S. Physical Therapy in a report on Friday, May 3rd. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $113.54.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Article: No Load Funds

Insider Buying and Selling by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.